Sharon Curran

Clinigen Ltd. engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom.

Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom.

Part of Eli Lilly & Co., Eli Lilly & Company (Ireland) Ltd. is an Irish pharmaceutical company that focuses on creating medicines to improve people's lives globally. The company is based in Dublin, Ireland. The company partners with government and regulatory agencies to ensure the safety of patients who use their medicines. Eli Lilly & Company has been a leader in the fight against Alzheimer's disease for over 30 years and conducts clinical development and research ethics to improve their products.

Part of Abbott Laboratories, Abbott Ireland Ltd. is an Irish company that helps people live healthier lives through their life-changing technology. The company is based in Dublin, Ireland. The company's technology focuses on keeping the heart healthy, nourishing the body at every stage of life, improving movement, and providing information, medicines, and breakthroughs to manage health.

Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland.